Bank of America’s Enveric Biosciences ENVB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $29 | Buy |
+24
| New | +$29 | ﹤0.01% | 7153 |
|
2025
Q1 | – | Sell |
-180
| Closed | -$65 | – | 7270 |
|
2024
Q4 | $65 | Buy |
180
+7
| +4% | +$3 | ﹤0.01% | 6896 |
|
2024
Q3 | $82 | Buy |
173
+9
| +5% | +$4 | ﹤0.01% | 6819 |
|
2024
Q2 | $103 | Buy |
164
+64
| +64% | +$40 | ﹤0.01% | 6793 |
|
2024
Q1 | $100 | Hold |
100
| – | – | ﹤0.01% | 6492 |
|
2023
Q4 | $130 | Hold |
100
| – | – | ﹤0.01% | 6420 |
|
2023
Q3 | $238 | Sell |
100
-1
| -1% | -$2 | ﹤0.01% | 6462 |
|
2023
Q2 | $340 | Buy |
101
+1
| +1% | +$3 | ﹤0.01% | 6458 |
|
2023
Q1 | $166 | Hold |
100
| – | – | ﹤0.01% | 6609 |
|
2022
Q4 | $208 | Hold |
100
| – | – | ﹤0.01% | 6713 |
|
2022
Q3 | $0 | Buy |
+100
| New | – | ﹤0.01% | 6992 |
|
2021
Q2 | – | Sell |
-10
| Closed | – | – | 6958 |
|
2021
Q1 | $0 | Buy |
+10
| New | – | ﹤0.01% | 6727 |
|
2018
Q4 | – | Sell |
-3,005
| Closed | -$4K | – | 6356 |
|
2018
Q3 | $4K | Buy |
+3,005
| New | +$4K | ﹤0.01% | 6117 |
|